anisodamine has been researched along with Choledocholithiasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, XM; Gao, J; Ke, S; Ma, RL; Ning, CM; Qian, XJ; Sun, WB; Xin, ZH; Zhou, YM | 1 |
| Chen, YK; Fu, Y; Jia, CK; Qin, QF; Weng, J; Yang, QZ; Yu, WM | 1 |
1 trial(s) available for anisodamine and Choledocholithiasis
| Article | Year |
|---|---|
Anisodamine accelerates spontaneous passage of single symptomatic bile duct stones ≤ 10 mm.
Topics: Aged; Chi-Square Distribution; China; Cholangiopancreatography, Magnetic Resonance; Choledocholithiasis; Common Bile Duct; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Liver Function Tests; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Solanaceous Alkaloids; Time Factors; Treatment Outcome | 2013 |
1 other study(ies) available for anisodamine and Choledocholithiasis
| Article | Year |
|---|---|
Hepatectomy with primary closure of common bile duct for hepatolithiasis combined with choledocholithiasis.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Choledocholithiasis; Common Bile Duct; Cost Savings; Cost-Benefit Analysis; Dexamethasone; Drainage; Feasibility Studies; Female; Glucocorticoids; Hepatectomy; Hospital Costs; Humans; Length of Stay; Lithiasis; Liver Diseases; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Solanaceous Alkaloids; Time Factors; Treatment Outcome; Young Adult | 2015 |